New in-silico-designed protein ‘probes' could pave the way to early diagnosis of neurodegenerative diseases
-
Loading... - Adrien Gauthier
- 22 Sep 2022
- 59 Views
- 0 Like
- 0 Comment
A team of researchers from the IIT-Istituto Italiano di Tecnologia (Italian Institute of Technology) has designed in silico “molecular probes” able to track the progress of a protein that misbehaves in different neurodegenerative diseases, such as Amyotrophic Lateral Sclerosis (ALS) and Fronto-Temporal Dementia (FTD). The probes can be used to study the behavior of the target protein in cell and were tested in collaboration with Sapienza University of Rome, Centre for Genomic Regulation n Barcellona, University of Edinburgh and Kings College London. The research study has been published in Nature Communications.
Created by the “RNA Systems Biology” group at IIT in Genoa, the probes consist of computer-designed RNA molecules that bind to a neurodegeneration-associated protein named TDP-43. This protein is present in numerous cases of Amyotrophic Lateral Sclerosis (ALS) and Fronto-Temporal Dementia (FTD), where it aggregate creating insoluble protein blobs in neural cells, altering their metabolism and function.
The research team was inspired by the protein's natural interactions with RNA molecules to design molecular probes, which are called “aptamers”, literally molecules made to fit one single target. Their main goal was to obtain a novel approach for tracking the aggregation of neurodegeneration-associated proteins at the very first steps of the process.
"Using our own algorithms, we designed RNA aptamers specific for TDP-43 and used them together with advanced microscopy techniques to follow the protein transition towards its aggregated forms” explains Gian Gaetano Tartaglia, principal investigator of the RNA System Biology Lab. “We can identify TDP-43 aggregates as small as 10 nanometers which, to our knowledge, is the best resolution achieved so far when visualising protein aggregates".
These aptamers could be used to study, at the molecular level, the phenomenon of abnormal protein aggregation typical of several neurodegenerative diseases and would, therefore, pave the way for the development of early diagnosis tools for these disorders. Read More...
